Xeris Pharmaceuticals Inc (XERS) stock news · rev $291.8M
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
This XERS news page leads with what Xeris Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for XERS yet. We will not pad this page with generic market recap.
Latest reported XERS revenue for 2025-12-31 was $291.8M. Net income was $554.0K. Revenue was up 43.7% from 2024-12-31 to 2025-12-31. XERS currently screens at market cap $760.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the XERS stock page; for the tape open the quote page.
XERS stock news FAQ
What are XERS's latest revenue and net income?
Latest cached Xeris Pharmaceuticals Inc (XERS) revenue for Dec 31, 2025 was $291.8M. Net income was $554.0K. Statements: https://lician.com/financials/xers
How did XERS revenue change from the prior cached period?
Cached Xeris Pharmaceuticals Inc (XERS) revenue was up 43.7% from $203.1M (Dec 31, 2024) to $291.8M (Dec 31, 2025). Statements: https://lician.com/financials/xers
What is XERS's market cap?
Xeris Pharmaceuticals Inc (XERS) market cap is $760.7M on the latest cached fundamentals snapshot.
What kind of company is XERS?
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Where is XERS stock news listed?
Cached stock news for Xeris Pharmaceuticals Inc (XERS) is listed at https://lician.com/news/xers. Filings: https://lician.com/sec/xers
Not investment advice.